EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Biology And Management Of Multiple Myeloma Current Clinical Oncology 1st James R Berenson

Name: Biology And Management Of Multiple Myeloma Current Clinical Oncology 1st James R Berenson
SKU: BELL-2167312
Price: 31.00 USD
Availability: InStock
Rating: 4.8 (64 reviews)

SKU: BELL-2167312

$ 31.00 ~~$ 45.00~~ (-31%)

4.8

64 reviews

Biology And Management Of Multiple Myeloma Current Clinical Oncology 1st James R Berenson instant download after payment.

Publisher: Humana Press

File Extension: PDF

File size: 4.1 MB

Pages: 380

Author: James R. Berenson

ISBN: 0896037061, 9780896037069

Language: English

Year: 2004

Edition: 1st

Product desciption

Biology And Management Of Multiple Myeloma Current Clinical Oncology 1st James R Berenson by James R. Berenson 0896037061, 9780896037069 instant download after payment.

Expert physicians and clinical researchers summarize and explain all the recent advances in the biology and treatment of bone marrow-based malignancy. On the biological side, the authors show the characteristics of the malignant cell and describe the significant roles played by oncogenic changes, chromosomal anomalies, Kaposi's sarcoma herpes virus, and cytokines. New epidemiological findings and prognostic factors are also analyzed. On the clinical side, the authors provide a comprehensive review of conventional treatment regimens, as well as a discussion of newer experimental approaches involving immunologic targeting, inhibitors of drug resistance, and antitumor agents.